icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
Factors associated with hepatitis C treatment uptake among people who inject drugs in a population based data linkage study Next Steps
 
 
  EASL: HCV treatment outcomes among current and remote people who inject drugs (PWID): real life data - (05/07/19)
 
EASL: A comparison of currently available direct acting antiviral HCV therapy in Canada - On the path to elimination - (05/07/19)
 
EASL: Immediate versus delayed hepatitis C treatment in the United Kingdom: A pan-genotypic cost-effectiveness analysis - (04/15/19)
 
Barriers to Treatment/Cascade - linkage to care/testing !!! EASL: Patient Flow Across Physician Specialties Over the Course of the Hepatitis C Care Cascade: A Real-World Analysis From the United States - (04/13/19)
 
EASL: The short and long term impact of scaling up treatment for hepatitis B and C on disease burden - (05/08/19)
 
EASL: HCV Elimination Off-Track WHO Targets/Countries Estimates - Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targets - (04/15/19)
 
USA Amongst The Worst in Path Towards HCV Elimination - EASL: Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targets - (04/15/19)
 
EASL: A Novel Approach to Funding HCV and HBV Treatment for all -Uzbekistan Pilot Project - (05/08/19)
 
EASL: New in France: Universal Access for HCV-treatment as demonstrated by a nationwide real-world cohort - (05/07/19)
 
EASL: Achieving accelerated elimination of hepatitis C virus infection by 2025: a case study in France - (04/15/19)
 
EASL: Reinfection following successful HCV DAA therapy among people with recent injecting drug use - (04/15/19)
 
EASL: Hepatitis C virus reinfection following antiviral treatment among people who inject drugs: A systematic review and meta-analysis - (04/15/19)
 
Reported by Jules Levin
EASL 2019 April 10-14 Vienna

0513191

0513192

0513193

0513194

0513195

0513196